Richard Katz, MD, MHA

Richard Katz, MD, MHA, is a strategic leader and neuroscience researcher with expertise in CNS disorders, aging, and geriatric depression. His research, published in leading medical journals, explores antidepressant treatment response, cognitive control, and sensory processing in aging. Dr. Katz's expertise in cell-based biologics and regenerative medicine is underscored by his direct experience with autologous cell therapies in the pharmaceutical and medical technology industries. This background provides him with valuable insight into the complexities and potential of cell-based therapies, a field that holds significant promise in addressing a range of conditions, including those affecting the CNS. His work reflects a commitment to advancing innovative treatment modalities that align with current progress in regenerative medicine.